Medication Error Pharmacy Policy
Contents |
information and have no effect once you leave the Medscape site.
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines,
Ma Borp Qre Law
Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs medication error reporting massachusetts Home Drugs Drug Safety and Availability Medication Errors Medication Errors Related to Drugs Share Tweet describe the difference between internal and external reports Linkedin Pin it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division of Medication Error http://www.medscape.com/viewarticle/406977 Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or http://www.fda.gov/drugs/drugsafety/medicationerrors/ lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adve
Portal Advanced search Portal Home Search Titles A-Z Subjects Keywords Series and Periodicals Publishers Authors A-Z Regions Countries Index Sub-collections Public sub-collections Loading... Expand Document|Expand Chapter|Full TOC|Printable HTML version Subjects & KeywordsMedicine Access and http://apps.who.int/medicinedocs/en/d/Js4882e/7.2.html Rational Use > Rational UseMedicine Access and Rational Use > SelectionKeywords > appropriate useKeywords > cost-effectivenessKeywords > Drug and Therapeutics Committee - DTCKeywords > drug use evaluationKeywords > evidence - effectiveness and efficiencyKeywords > formulary - processKeywords > Good Prescribing Practice (GPP)Keywords > medicine use - investigatingKeywords > new medicines - efficacy and safetyKeywords > selection of medicinesDrug and Therapeutics Committees - A Practical Guide medication error (2003; 155 pages) [French] [Spanish] [Vietnamese] Related linkshttp://www.who.int/medicines/areas/rational_use/en/http://www.who.int/selection_medicines/en/ Table of Contents Acronyms and abbreviations Preface 1. Introduction 1.1 Why are drug and therapeutics committees (DTCs) needed? 1.2 Goals and objectives of the DTC 1.3 Functions of the DTC 1.4 Role of the DTC in the drug management cycle 2.Structure and organization of a drug and therapeutics committee 2.1 Principles in setting up a DTC 2.2 Steps medication error reporting in setting up and managing the DTC Annex 2.1 Example of a declaration of interest form Annex 2.2 Model terms of reference for a DTC in Zimbabwe Annex 2.3 Example of a mandate for a DTC: excerpts from the Zimbabwe National Drug Policy 1998 3. Managing the formulary process 3.1 The formulary process 3.2 The formulary list (essential medicines list) 3.3 Formulary manual 3.4 Standard treatment guidelines (STGs) Annex 3.1 Application forms to be filled in by applicants when applying for a new drug to be added to the hospital formulary list Annex 3.2 Drug information included in a comprehensive formulary 4.Assessing new medicines 4.1 The need for critical assessment of new medicines 4.2 Sources of information to assess new medicines 4.3 Assessing the efficacy and safety of new medicines from the literature 4.4 Measuring and comparing clinical treatment outcomes 4.5 Measuring and comparing drug costs Annex 4.1 Sources of information Annex 4.2 Checklist to detect common problems encountered in articles 5.Ensuring medicine safety and quality 5.1 The need for ensuring medicine safety and quality 5.2 Monitoring and addressing medication errors 5.3 Monitoring and ensuring medicine quality 5.4 Safety of medicines Annex 5.1 Basic anal
be down. Please try the request again. Your cache administrator is webmaster. Generated Wed, 19 Oct 2016 01:13:20 GMT by s_ac4 (squid/3.5.20)